• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Investigation of drug transport function through biological membranes and physiological role in endotoxemia

Research Project

Project/Area Number 13672417
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionNagoya University

Principal Investigator

HASEGAWA Takaaki  Nagoya University, School of Medicine, Professor, 医学部, 教授 (80198720)

Co-Investigator(Kenkyū-buntansha) KITAICHI Kiyoyuki  Nagoya University, School of Medicine, Research Associate, 医学部, 助手 (40301220)
TAKAGI Kenji  Nagoya University, School of Medicine, Associate Professor, 医学部, 助教授 (80126870)
Project Period (FY) 2001 – 2002
Keywordsendotoxin / membrane transport / transporters / P-glycoprotein / blood-brain barrier / cytokines
Research Abstract

Results obtained from this research are represented as follows :
1. The involvement of cytokines and mediators, such TNF-α, IL-1 and PAF, in endotoxin-induced decreases in the content of CYP and protein levels of CYP3A2 and 2C11 appears to be small.
2. Some quinolone antimicrobial agents increased the intracellular accumulation of doxorubicin, a substrate of P-glycoprotein, in P-glycoprotein-dependent anticancer drug resistant cells, suggesting that they can reverse anticancer drug resistance of tumors. They are excreted into the bile by a P-glycoprotein-mediated transport system.
3. Endotoxin did not change the activity of glucuronidation, but decreased sparfloxacin and its glucuronide due to impairment of Mrp2- and/or P-glycoprotein-mediated hepatobiliary transport systems and renal handling.
4. The expression of Mdrla mRNA in both liver and kidney decreased 6 h after endotoxin injection and returned to control level. Endotoxin decreased P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 by decreasing the expression of Mdrla, which is likely due to increased plasma TNF-α levels.
5. Endotoxin did not induce histopathological changes in the brain capillaries, and had no effect on the brain capillary integrity and doxorubicin transport across the blood-brain barrier (BBB) in mice. Endotoxin did not change the function and expression of P-glycoprotein in the brain. It is likely that P-glycoprotein function might be sufficient to transport doxorubicin despite of decreased levels of P-glycoprotein in the brain.
6. Shiga-like toxin II impairs the BBB function and doxorubicin transport across the BBB, while induces upregulation of P-glycoprotein, which are different from results by endotoxin injection. The discrepancy between endotoxin and Shiga-like toxin II may be explained by the difference in the contents of cytokine production.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Hidemura K.: "Shiga-like toxin II impairs hepatobiliary transport of doxorubicin by down-regulation of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats"Antimicrob Agents Chemother. 47(in press). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsushima M.: "The expression of mRNA for calcitonin receptor-like receptor/receptor-activity modifying proteins in rat peritoneal mast cells"Eur J Pharmacol. 464. 111-114 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitaichi K.: "Altered pharmacokinetic properties of methamphetamine in rats having behavioral sensitization to methamphetamine"Eur J Pharmacol. 464. 39-48 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Zhao Y.L.: "Shiga-like Toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice"Brain Res. 966. 246-253 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Zhao Y.L.: "Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice"Eur J Pharmacol. 446. 115-123 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Zhao Y.L.: "Shiga-like Toxin II derived from E. coli O157 : H7 modifies renal handling of levofloxacin in rats"Antimicrob Agents Chemother. 46. 1522-1528 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 長谷川 高明: "新しい図解生物薬剤学"南山堂(印刷中). (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hidemura,K., Zhao,Y.L., Ito,K., Nakao,A., Kanazawa,H., Tafcagi,K., Ohta,M., Hasegawa,T.: "Shiga-like toxin II impairs hepatobiliary transport of doxorubicin by down-regulation of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats"Antimicrob. Agents Chemother.. in press. (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsushima M., Kitaichi K., Tatsumi Y., Hasegawa T., Takagi K.: "The mRNA expression of calcitonin receptor-like receptor/receptor activity modifying proteins in rat peritoneal mast cells"Eur.J.Pharmacol. 464. 111-114 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitaichi,k,, Morishita,Y, Doi,Y, Ueyama,J., Matsushima,Y, Zbao,Y.L, Takagi,K., Hasegawa,T.: "Increased plasma concentration and brain penetration of methamphetamine in benaviorally sensitized rats"Eur.J.Pharmacol.. 464. 39-48 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Zhao Y.L., Du,J., Kanazawa,H., Cen,X.B., Takagi,K., Kitaichi,K., Tatsumi,Y., Takagi,K., Ohta,M. and Hasegawa,T.: "Shiga-like toxin II modifies brain distribution of a P-glycopibtein substrate, doxorubicin, and P-glycoprotein expression in mice"Brain Res.. 956. 246-253 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Zhao,Y.L, Du,J., Kanazawa,H., Sugawara,K., Takagi,K., Kitaichi,K., Tatsumi,K., Takagi,K. and Hasegawa,T.: "Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice"Eur.J.Pharmacol.. 445. 115-123 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Zhao,Y.L., Cen,X.B., Ito,M., Yokoyama,K., Kitaichi,K., Nadai,M., Ohta,M., Takagi,K. and Hasegawa,T.: "Shiga-like Toxin II derived from Escherichia coli O157 : H7 modifies renal handling of levofloxacin in rats"Antimicrob. Agents Chemother.. 46. 1522-1528 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hasegawa,T.: "New Biological Pharmaceutics, 「Factors influencing varidations in Phannacokinetics」 「pharmacodynamics and Toxicokinetics」"Nanzando. in press. (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi